Philips Ultrasound Warns Customers Over Lumify Instructions; FDA Cites 8 Injuries, 4 Deaths

This is a safety signal, not a product recall, and the distinction matters: Philips is revising instructions rather than pulling devices, which suggests the exposure sits in how Lumify is used rather than in the hardware itself. The reported injuries and deaths are serious enough to draw FDA attention, yet the agency's role here appears limited to acknowledging the customer letter. For clinicians and facilities running Lumify, the practical question is whether updated guidance changes bedside practice. Whether the reported harms trace to user error, labeling gaps or something else remains the open question.